CA2974853C — 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
Assigned to Bayer Pharma AG · Expires 2023-02-21 · 3y expired
What this patent protects
Compounds of formula (l) (see formula I) processes for their production and their use as Bub 1 kinase inhibitors, and which may therefore be useful as pharmaceuticals for the treatment or prophylaxis of hyperproliferative diseases and/or disorders responsive to induction of cell …
USPTO Abstract
Compounds of formula (l) (see formula I) processes for their production and their use as Bub 1 kinase inhibitors, and which may therefore be useful as pharmaceuticals for the treatment or prophylaxis of hyperproliferative diseases and/or disorders responsive to induction of cell death, such as haematological tumours, solid tumours and/or metastases thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.